Keros Therapeutics, Inc.

Ownership Transactions Reported by 18 Insiders

Symbol
KROS on Nasdaq
Location
1050 Waltham Street, Suite 302, Lexington, MA

Insiders trading volume in the past year

Keros Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Pontifax Management 4 G.P. (2015) Ltd. 10%+ Owner $55.5M Nov 29, 2022
ADAR1 Capital Management, LLC 10%+ Owner $55M +$9.46M +20.8% Apr 9, 2025
Orbimed Advisors Llc Director $5.26M -$11M -67.7% Aug 13, 2024
Carl L. Gordon Director $5.26M -$11M -67.7% Aug 13, 2024
Jennifer Lachey Chief Scientific Officer $4.31M Jul 15, 2022
Christopher Rovaldi Chief Operating Officer $2.64M Feb 18, 2025
Keith Regnante Chief Financial Officer $1.94M Feb 18, 2025
Yung H. Chyung Chief Medical Officer $1.94M Feb 18, 2025
Jasbir Seehra CHIEF EXECUTIVE OFFICER, Director $90.7K Apr 4, 2025
Jean Jacques Bienaime Director $9.06K Jun 3, 2024
Julius Knowles Director May 30, 2024
Tomer Kariv Director, 10%+ Owner May 30, 2024
Ran Nussbaum Director, 10%+ Owner May 30, 2024
Nima Farzan Director May 30, 2024
Mary Ann Gray Director May 30, 2024
Alpna Seth Director May 30, 2024
Simon Peter Cooper Chief Medical Officer Feb 13, 2024
Claudia Ordonez Chief Medical Officer Jun 11, 2021

Recent Insider Transactions by Companies or Individuals for Keros Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.